Bank Hapoalim B.M.
Bank Hapoalim B.M. (BKHYY) Financial Performance & Income Statement Overview
Review Bank Hapoalim B.M. (BKHYY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Bank Hapoalim B.M. (BKHYY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Bank Hapoalim B.M. BKHYY financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.48B | $5.63B | $5.73B | $5.09B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $5.48B | $5.63B | $5.73B | $5.09B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $1.49B |
| Operating Expenses | $2.81B | $5.63B | $2.11B | $2.03B |
| Total Costs & Expenses | $2.81B | $5.63B | $2.11B | $2.03B |
| Interest Income | $8.69B | $9.61B | $9.11B | $8.09B |
| Interest Expense | $4.51B | $5.03B | $4.73B | $4.28B |
| Depreciation & Amortization | $190.00M | $191.00M | $183.00M | $200.00M |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $2.68B | $0.00 | $3.64B | $3.10B |
| Operating Income Ratio | $0.49 | $0.00 | $0.64 | $0.61 |
| Other Income/Expenses (Net) | -$323.00M | $3.16B | $35.00M | $24.00M |
| Income Before Tax | $2.35B | $3.16B | $3.67B | $3.07B |
| Income Before Tax Ratio | $0.43 | $0.56 | $0.64 | $0.60 |
| Income Tax Expense | $804.00M | $1.20B | $1.40B | $1.16B |
| Net Income | $1.55B | $1.91B | $2.24B | $1.94B |
| Net Income Ratio | $0.28 | $0.34 | $0.39 | $0.38 |
| EPS | $1.16 | $1.43 | $1.67 | $1.45 |
| Diluted EPS | $1.16 | $1.43 | $1.67 | $1.45 |
| Weighted Avg Shares Outstanding | $1.33B | $1.33B | $1.34B | $1.34B |
| Weighted Avg Shares Outstanding (Diluted) | $1.33B | $1.33B | $1.34B | $1.34B |
Over the past four quarters, Bank Hapoalim B.M. demonstrated steady revenue growth, increasing from $5.09B in Q1 2024 to $5.48B in Q4 2024. Operating income reached $2.68B in Q4 2024, maintaining a consistent 49% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income dropped to $1.55B, with EPS at $1.16. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan